Pt No | Age (years) | Sitea | Stageb | Chemotherapyc | Overall RECIST responsed | SUV60, ave (preRx) | SUV60, max (preRx) | Percentage Change SUV60, ave | Percentage Change SUV60, max | Baseline FDG SUV60, ave | Baseline FDG SUV60,max | Ki-67 (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 63 | GEJ | T4N1M1 | EOX | PR | 5.92 | 9.45 | −35.16 | −54.49 | – | – | 43 |
2 | 54 | Distal | T3N0 | ECX, surgery | – | 4.6 | 4.52 | −25.65 | −5.75 | 5.93 | 4.38 | – |
3 | 68 | Distal | T3N0M1 | EOX | SD | 5.32 | 7.47 | −2.26 | 4.95 | 6.76 | 5.63 | 87 |
4 | 76 | GEJ | T3N1M1 | ECX | PR | 4.97 | 7.25 | 6.44 | 5.66 | 21.45 | 19.96 | 29 |
5 | 71 | GEJ | T3N0M0 | EOX | SD | 6.08 | 9.96 | 11.51 | 11.14 | 14.91 | 14.06 | 23 |
6 | 64 | GEJ | T4N1M1 | EOX | SD | 5.5 | 8.85 | −30.73 | −47.57 | 10.44 | 9.03 | – |
7 | 65 | Gastric | T3N1M0 | EOX, Surgery | PR | 4.14 | 7.62 | −15.22 | −16.93 | – | – | – |
7e | 3.65 | 8.87 | 1.92 | 29.76 | ||||||||
8 | 60 | Distal | T3N1M0 | ECX, surgery | SD | 7.7 | 13.36 | −29.61 | −33.08 | – | – | – |
9 | 54 | Gastric | T3N1M0 | EOX/STO3 | SD | 3.66 | 5.93 | −24.86 | −25.46 | – | – | 51 |
10 | 69 | Distal | T3N0M0 | ECX, surgery | SD | 4.79 | 9.3 | −18.99 | −24.09 | 13.88 | 12.24 | 67.5 |